Redeye updates on W5 Solution post Q2-results where sales were stronger than expected while results ...
The share price has declined by 14% since the Q1 report.
Alzecure har på kort tid sålt rättigheterna till bolagets båda Alzheimer-projekt NeuroRestore och Al...
Redeye provides its initial take on CSG's Q1 2026/2027 results, which came in weaker than expected, ...
Redeye comments on W5 Solutions Q2-report where the company saw stronger-than-expected topline while...
NoHo Partners delivered a robust Q2 performance as the Norwegian operations normalised and the Finni...
Yesterday, QBY announced the acquisition of a 51% stake in Hamburg-based GITG, a c.
NoHo Partners reported Q2 EBIT of EUR 9.1m (+22% y/y), 15% above Vara Research consensus and 14% abo...
Orderboken för försvarsbolaget präglas av högmarginalleveranser som väntas rulla ut och ger stark vi...
Q2 net sales and clean EBITA were above our expectations.
Advanced Blockchain AG (ABAG) continued its far-reaching balance sheet reset in fiscal year 2025.
Zefiro Methane Corp. is a publicly-traded environmental services provider focused on the U.
This morning, Nekkar's subsidiary, Globetech, announced its second bolt-on acquisition by acquiring ...
Redeye comments on qbeyond's acquisition of GITG. While we are encouraged to see qbeyond entering th...
CMS has published the FY2027 IPPS final rule, confirming the proposed DRG reclassification for CERAM...
Redeye comments on Fable Media Group's appointment of Carl Magnusson, currently Head of Operations, ...
Bittium will publish its H1'26 report on August 7. Publicly announced orders during Q2'26 totalled €...
Pentixapharm sits at the intersection of a high-prevalence indication and one of the fastest- growin...
Organic growth was above our Q2 forecast, but the company has recently faced some profitability issu...
Aktia reported positive momentum on both NII and AUM flows.
